Statera Biopharma announced it raised $577,000 in an initial filing from an offering of $765,000

Company

Location

About

Statera Biopharma’s foundation is based on restoring immune health through the leveraging of complex, pleiotropic beneficial effects. At Statera, we embrace the idea that beneficial and safe drugs act as natural analogs in a paracrine fashion, as well as a trans-activator to resolve disease and elicit homeostasis.